Beyond Screening: Supporting the Mental Health of NICU Parents
Parents of infants in the NICU face high rates of depression, anxiety, stress, and trauma. Are we doing enough to identify their needs—and provide meaningful mental health support?
A Link Between Childhood Adversity and Polycystic Ovary Syndrome
In this North American cross-sectional study, higher exposure to early life adversities was associated with a higher lifetime prevalence of physician-diagnosed PCOS/PMOS. The findings add to growing evidence that childhood adversities may have lasting effects on reproductive health.
Beyond Reproductive Health: The Psychiatric Burden of Polyendocrine Metabolic Ovarian Syndrome (PMOS or PCOS)
Women with PMOS have significantly higher rates of depression and anxiety. Routine screening and integrated care are essential for improving psychiatric and reproductive outcomes.
Folic Acid Supplementation: When to Start? How Long to Continue?
Folic acid supplementation before and during early pregnancy substantially reduces the risk of neural tube defects. Emerging research suggests that folic acid may have beneficial effects on neurodevelopment that extend beyond the first trimester. We review the evidence on the timing of folic acid supplementation and findings from the FASSTT randomized controlled trial, which examined whether supplementation during the second and third trimesters was associated with improved cognitive outcomes in children.
Essential Reads: Why All Women of Reproductive Age Should Take Folic Acid
Folic Acid Awareness Week (Sept 13-19, 2026) focuses on the importance of daily folic acid supplements for women to prevent birth defects, as diet alone is often insufficient.
Quetiapine Use During Pregnancy: What Do We Know About Reproductive Safety?
For women who require treatment with quetiapine during pregnancy, the available reproductive safety data are generally reassuring. The largest body of evidence does not suggest a meaningful increase in major congenital malformations, while metabolic effects, particularly gestational diabetes, remain an important consideration.
September is Suicide Prevention Awareness Month: Emergency Resources for Individuals with Perinatal Mental Health Issues
If you or someone you know is in crisis, confidential support is available.
Atomoxetine and Stimulants During Pregnancy: What Do We Know About Pregnancy Outcomes?
A new study examines pregnancy outcomes among women using stimulants or atomoxetine during pregnancy, finding modest increases in some complications with stimulant use while highlighting important limitations of observational data.
ADHD Stimulants and Pregnancy: New Study Examines Risks of Continued Treatment
A large claims-based study found no increased risk for most outcomes with first-trimester stimulant exposure during pregnancy, but higher risks when use continued later in pregnancy.
Lamotrigine and Menopausal Hormone Therapy: What Women Need to Know
Estrogen-containing menopausal hormone therapy (MHT) may lower blood levels of lamotrigine, potentially reducing its effectiveness in some women with bipolar disorder. What do we know about this interaction, and does the risk differ with oral, transdermal, or vaginal estrogen?